This talk will discuss the strategy and selection criteria used at DuPont to build a strong portfolio of Biomaterials, including specific examples from commercial products and key research programs. DuPont has primarily focused on new products from renewable resources that have differentiated value propositions, rather than on drop-in renewable routes to existing petro-chemicals. This approach comes from DuPont’s heritage as an Advanced Material supplier, and is different form many other players in the Biomaterials space that are either integrating forward from a strong position in agricultural commodities or building on strength in biotechnology-based conversion processes. From a technology perspective, DuPont is “agnostic”, selecting the best technology or, more often, set of technologies, that are required for each individual program. Most of DuPont’s Biomaterials programs involve combinations of chemistry, biology, materials science, and engineering to create cost-effective new Biomaterials with better performance than petro-based incumbents, and, critically, to work with customers to develop successful applications of these materials. Specific examples from commercial and near-commercial product lines will be shared to illustrate these points.

Building a robust biomaterials portfolio: An overview of DuPont’s strategy and programs

251st National Meeting (2016)

The official archive and repository for all ACS Meetings & Expositions abstracts and select posters or presentations.